The formalin test: an evaluation of the method

Pain

Volumn 51, Issue 1, 1992, Pages 5-17

  Tjølsen, Arne ^a   Berge, Odd Geir ^b   Hunskaar, Steinar ^a   Rosland, Jan Henrik ^a   Hole, Kjell ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

(Mice); (Rats); C fibre; Formalin test; Nociception; Pain measurement

Indexed keywords

FORMALDEHYDE;

ANIMAL EXPERIMENT; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; REVIEW; SENSORY NERVE;

ANIMAL; EVALUATION STUDIES; FORMALDEHYDE; PAIN;

EID: 0026674117     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(92)90003-T     Document Type: Review

References (170)

1. Peripheral and central antinociceptive actions of ethylketocyclazocine in the formalin test
2. Noncompetitive antagonism of morphine analgesia by diazepam in the formalin test
3. Brainstem lesions dissociate neural mechanisms of morphine analgesia in different kinds of pain
4. Dissociation of the mechanisms of stimulation-produced analgesia in tests of tonic and phasic pain
5. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats
6. Effect of 5-hydroxytryptamine precursors on morphine analgesia in the formalin test
7. Apparent lack of tolerance in the formalin test suggests different mechanisms for morphine analgesia in different types of pain
8. Morphine analgesia and tolerance in the tail-flick and formalin tests: dose-response relationships
9. Morphine analgesia in tail-flick and formalin pain tests is mediated by different neural systems
10. Single nerve capsaicin: effects on pain and morphine analgesia in the formalin and foot-flick tests
11. A dose-ratio comparison of mu and kappa agonists in formalin and thermal pain
12. The stress of a novel environment reduces formalin pain: possible role of serotonin
13. Comparison of different animal models of chronic pain
14. Ontogeny of lateral preoptic unit activity in rats
15. The formalin test: a tonic pain model in the primate
16. Unilateral knife cuts produce ipsilateral suppression of responsiveness to pain in the formalin test
17. Noradrenergic and opioidergic influences on the antinociceptive effect of clomipramine in the formalin test in rats
18. Response of serotonincontaining neurons in nucleus raphe magnus to morphine, noxious stimuli, and periaqueducta) gray stimulation in freely moving cats
19. Mild analgesics, a review of their clinical pharmacology
20. Hyperbaric exposure and morphine alters the pattern of behavior in the formalin test
21. Subcutaneous formal in induces a segmental release of met-enkephalin-like material from the rat spinal cord
22. Studies on the acute inflammatory response. I. Involvement of the central nervous system in certain models of inflammation
23. Analgesic action of clonixin. nifedipine and morphine using the formalin test
24. Quaternary naltrexone reveals the central mediation of conditional opioid analgesia
25. Analgesia produced by centrally administered DAGO, DPDPE and U50488H in the formalin test
26. d-Ala2,Leu5,Cys6:enkephalin: short-term agonist effects and long-term antagonism at delta opioid receptors
27. Increased reactivity to chemical but not to heat noxious stimuli in mice producing anti-idiotypic antibodies for substance P
28. Antinociceptive profile of intracerebroventricular salmon calcitonin and calcitonin gene-related peptide in the mouse formalin test
29. Effects of pain, morphine and naloxone on the duration of animal hypnosis
30. Swim stress reduces chronic pain in mice through an opioid mechanism
31. Pain measurement: an overview
32. Multidimensional pain requires multidimensional scaling, Issues in pain measurement
33. Application of the formalin test to the study of orofacial pain in the rat
34. Behavioral evidence in rats for a peptidergic-noradrenergic interaction in cutaneous sensory and vascular function
35. Effects of peripheral antisympathetic treatments in the tail-flick, formalin and autotomy tests
36. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection
37. Morphine injected into the habenula and dorsal posteromedial thalamus produces analgesia in the formalin test
38. Habenular stimulation produces analgesia in the formalin test
39. Unilateral analgesia produced by intraventricular morphine
40. Use of the formalin test in evaluating analgesics
41. Peptide fragments derived from the beta-chain of hemoglobin (hemorphins) are centrally active in vivo
42. Pain modulation by 5-hydroxytrypt-aminergic agents and morphine as measured by three pain tests
43. Effects of cholinergic and dopaminergic agents on pain and morphine analgesia measured by three pain tests
44. Pain modulation by adrenergic agents and morphine as measured by three pain tests
45. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones
46. Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin
47. The antinociceptive effects of prostaglandin antagonists in the rat
48. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats
49. Test-dependent changes in nociception after administration of the putative serotonin antagonist metitepin in mice
50. Shock-induced analgesia on the formalin test: effects of shock severity, naloxone, hypophysectomy, and associative variables
51. Odors released by stressed rats produce opioid analgesia in unstressed rats
52. Conditional analgesia, defensive freezing, and benzodiazepines
53. Delta opioid antagonist, 16-Me cyprenorphine, selectively attenuates conditional fear- and DPDPE-induced analgesia on the formalin test
54. Modulation of appetitively and aversively motivated behavior by the kappa opioid antagonist MR2266
55. Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide:Cys2Tyr3Orn5Pen7-amide
56. Tonic pain and social behavior in male rabbits
57. Changes in nociception after lesions of descending serotonergic pathways induced with 5,6-dihydroxytryptamine. Different effects in the formalin and tail-flick tests
58. Effects of the putative: 5-HT1A: receptor agonist 8-OH-2-(di-n-propylamino)-tetralin on nociceptive sensitivity in mice
59. Changes in nociception after 6-hydroxydopamine lesions of descending catecholaminergic pathways in mice
60. Development of tolerance to the antinociceptive effect of metergoline
61. Antinociceptive effects of (+ /−)-, (+)- and (−)-nefopam in mice
62. Changes in nociception after acute and chronic administration of zimelidine: different effects in the formalin test and the substance P behavioural assay
63. Antinociceptive effects of serotonergic reuptake inhibitors in mice
64. The effect of nonanoyl vanillylamide on the chemically-induced nociception (English abstract)
65. Hypercapnia depresses nociception: endogenous opioids implicated
66. Endogenous GABA released into the fourth ventricle of the rat brain in vivo is enhanced by noxious stimuli
67. Antinociceptive effects of the novel anxiolytic buspirone in three pain tests in rats
68. Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats
69. Electrophysiological evidence for a role of bradykinin in chemical nociception in the rat
70. Peripheral kappa-opioid modulation of the formalin response: an electrophysiological study in the rat
71. Evidence for spinal N-methyl-d-aspartate receptor involvement in prolonged chemical nociception in the rat
72. Effects of lesion and stimulation of rat hypothalamic arcuate nucleus on the pain system
73. Afferent C-fibre and A-delta activity in models of inflammation
74. Effects of naltrexone on learning and performance of conditional fear-induced freezing and opioid analgesia
75. Strain differences in reversal of conditional analgesia by opioid antagonists
76. Morphine blocks the increase in acid phosphatase in the substantia gelatinosa during pain
77. Morphine hyperalgesic effects on the formalin test in domestic fowl (Gallus gallus)
78. Similar effects of acetylsalicylic acid and morphine on immediate responses to acute noxious stimulation
79. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain
80. Antinociceptive effects of orphenadrine citrate in mice
81. Formalin test in mice, a useful technique for evaluating mild analgesics
82. Dissociation between antinociceptive and anti-inflammatory effects of acetylsalicylic acid and indomethacin in the formalin test
83. Lesions of the ascending serotonergic pathways and antinociceptive effects after systemic administration of p-chloroamphetamine in mice
84. Orphenadrine citrate increases and prolongs the antinociceptive effects of paracetamol in mice
85. Involvement of central serotonergic pathways in nefopam-induced antinociception
86. Mechanisms of orphenadrine-induced antinociception in mice: a role for serotonergic pathways
87. The analgesic effect of peripheral nerve stimulation in various tests of nociception in rats
88. Changes in acid phosphatase activity in the substantia gelatinosa in response to pain
89. Increase in substance P in the dorsal horn during a chemogenic nociceptive stimulus
90. Regulatory mechanisms for substance P in the dorsal horn during a nociceptive stimulus: axoplasmic transport vs. electrical activity
91. Nociception in crocodilescapsaicin instillation, formalin and hot plate tests
92. Formalin-evoked Fos expression in rat superficial dorsal horn: reduction by an NMDA antagonist
93. Systemic naloxone does not affect pain-related behaviour in the formalin test in rat
94. Amniotic fluid ingestion enhances opioid-mediated but not nonopioid-mediated analgesia
95. Endorphinergic mechanism in the central cardiovascular and analgesic effects of clonidine
96. Noxious stimuli and met-enkephalin release from nucleus reticularis gigantocellularis
97. Exposure to a cat produces opioid analgesia in rats
98. Observations relating to referred pain, visceromotor reflexes and other associated phenomena
99. Cocaine: evidence for supraspinal, dopamine-mediated, nonopiate analgesia
100. Chronic administration of desipramine and zimelidine changes the behavioural response in the formalin test in rats
101. The formalin test and the opioid nature of stress-induced analgesia
102. Activation of central mu-opioid receptors is involved in clonidine analgesia in rats
103. Naloxone blocks the formalin induced increase of substance P in the dorsal horn
104. Time course of the alteration in dorsal horn substance P levels following formalin: blockade by naloxone
105. Release of substance P into the superficial dorsal horn following nociceptive activation of the hindpaw of the rat
106. Tonic nociception in neonatal rats
107. Analgesia produced by brain stimulation: Evidence of a prolonged onset period
108. Histometrische Untersuchungen an Epidermis und Korium der Rattenpfote nach experimentellen Entzündungsreiz
109. Stimulation-produced analgesia (SPA) from brain-stem and diencephalic sites in the rat: relationships between analgesia, aversion, seizures and catalepsy
110. 6-Hydroxydopamine lesions of the ventral tegmentum abolish d-amphetamine and morphine analgesia in the formalin test but not in the tail flick test
111. Dopamine receptor subtypes and formalin test analgesia
112. Tonic analgesic effects of delta 9-tetrahydrocannabinol as measured with the formalin test
113. Formalin nociception in the mouse does not lead to increased spinal serotonin turnover
114. Tonic pain perception in the mouse differential modulation by three receptor-selective opioid agonists
115. Methodological refinements to the mouse paw formalin test. An animal model of tonic pain
116. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice
117. A noxious stimulus induces the preprotachykinin-A gene expression in the rat dorsal root ganglion: a quantitative study using in situ hybridization histochemistry
118. Preproenkephalin gene expression in the rat spinal cord after noxious stimuli
119. Naloxone reversal of morphine analgesia but failure to alter reactivity to pain in the formalin test
120. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord
121. New differences between the Wistar rat and Octodon degus, a putative laboratory animal resistant to morphine
122. Further studies on the understanding of Octodon degus natural resistance to morphine: a comparative study with the Wistar rat
123. Effect of subcutaneous formalin treatment on responses to bulboreticular nociceptive neurons in the rat
124. The effect of medetomidine, an alpha 2-adrenoceptor agonist, in various pain tests
125. Comparison of PD 117302, a kappa agonist, and morphine on colonie transit and formalin-induced pain in rats
126. Tonic pain time-dependently affects beta-endorphin-like immunoreactivity in the ventral periaqueductal gray matter of the rat brain
127. Functional activity mapping of the rat spinal cord during formalin-induced noxious stimulation
128. Functional activity mapping of the rat brainstem during formalin-induced noxious stimulation
129. Central beta-endorphin system involvement in the reaction to acute tonic pain
130. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord
131. Responses of trigeminal subnucleus oralis nociceptive neurones to subcutaneous formalin in the rat
132. The formalin test in mice: the influence of ambient temperature
133. The effect of diazepam on nociception in mice
134. Modification of the antinociceptive effect of morphine by acute and chronic administration of clomipramine in mice
135. Diazepam attenuates morphine antinociception test-dependently in mice
136. The formalin test in mice — effect of formalin concentration
137. Spinal pain suppression mechanisms may differ tor phasic and tonic pain
138. Supraspinal modulation of nociception in awake rats by stimulation of the dorsal column nuclei
139. Further studies concerning the participation of the adrenal cortex in the pathogenesis of arthritis
140. Peripheral analgesic actions of opioid peptides and morphine analogues (English abstract)
141. Studies of inflammatory pain response: related pain producing substance and endogenous opioid system (English abstract)
142. Local analgesic action and tissue irritability of nishika thesirol, a root canal disinfectant (English abstract)
143. Modified formalin test: characteristic biphasic pain response
144. Effects of morphine on two types of nucleus raphe dorsalis neurons in awake cats
145. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation
146. Topical application of morphine to the rat somatosensory cortex produces analgesia to tonic pain
147. Der Einfluss des zentralen Höhlengraus der Katze auf Schmerz bei Elektrostimulation im Aquädukt
148. Multivariate data analysis and experimental design in biomedical research
149. Involvement of medullary opioid-peptidergic and spinal noradrenergic systems in the regulation of formalin-induced persistent pain
150. Delta-opioid mediated inhibitions of acute and prolonged noxious-evoked responses in rat dorsal horn neurones
151. Increase in extracellular potassium level in rat spinal dorsal horn induced by noxious stimulation and peripheral injury
152. Experimental pain and neuropeptides
153. A modified formalin test for measuring analgesia in mice
154. Formalin-induced minor tremor response as an indicator of pain (English abstract)
155. Effect of neurotropin on hyperalgesia induced by prostaglandin E2, naloxone, melatonin and dark condition in mice
156. Different alpha-receptor subtypes are involved in clonidine-produced analgesia in different pain tests
157. Analgesia produced by injection of lidocaine into the lateral hypothalamus
158. Naloxone reverses the antinociceptive action of clonidine in spontaneously hypertensive rats
159. Antinociception vs motor effects of intrathecal vasopressin as measured by four pain tests
160. Lesions of bulbo-spinal serotonergic or noradrenergic pathways reduce nociception as measured by the formalin test
161. Antinociceptive effect of paracetamol in rats is partly dependent on the spinal serotonergic systems
162. Analgesia produced by injection of lidocaine into the anterior cingulum bundle of the rat
163. Systemic administration of naloxone produces analgesia in BALB/c mice in the formalin pain test
164. Analgesia produced by normal doses of opioid antagonists alone and in combination with morphine
165. Standardization of the rat paw formalin test for the evaluation of analgesics
166. The rat paw formalin test: comparison of noxious agents
167. Spinal c-fos induction by sensory stimulation in neonatal rats
168. Anti-inflammatory testing methods: comparative evaluation of indomethacin and other agents
169. Ethical guidelines for investigations of experimental pain in conscious animals